FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly cardiology, beam diagnostics, and can be used to predict a risk of developing atherosclerotic vascular changes. Essence of the invention consists in the fact that using the enzyme immunoassay to determine the level of blood serum intreleukin-33 and value of 7.81 pg/ml and less is a high risk of atherosclerotic vascular changes.
EFFECT: invention provides simplicity of research using widely used laboratory methods.
1 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING THE RISK OF DEVELOPING ATHEROSCLEROSIS BASED ON ANALYSIS OF IMMUNOLOGICAL PARAMETERS | 2018 |
|
RU2704959C1 |
| METHOD FOR PREDICTION OF ATHEROSCLEROSIS DEVELOPMENT | 2018 |
|
RU2704960C1 |
| METHOD FOR PREDICTION OF MULTIFOCAL ATHEROSCLEROTIC INVOLVEMENT | 2018 |
|
RU2704224C1 |
| METHOD FOR ATHEROSCLEROTIC LESIONS DEVELOPMENT RISK PREDICTION FOR CAUCASIANS | 2016 |
|
RU2618443C1 |
| METHOD FOR ATHEROSCLEROTIC LESIONS DEVELOPMENT RISK PREDICTION FOR KHAKASS | 2016 |
|
RU2618618C1 |
| METHOD OF RADIAL DIAGNOSTICS OF VISCERAL OBESITY | 2016 |
|
RU2610859C1 |
| METHOD FOR DETERMINING PROBABILITY OF PRESENCE OF UNSTABLE ATHEROSCLEROTIC PLAQUES IN CORONARY ARTERIES IN PATIENTS WITH CORONARY ATHEROSCLEROSIS | 2017 |
|
RU2665139C1 |
| EARLY DIAGNOSTIC TECHNIQUE FOR PULMONARY ARTERY THROMBOEMBOLIA | 2013 |
|
RU2513845C1 |
| METHOD FOR DETERMINING RADIATION-INDUCED ATHEROSCLEROTIC VASCULAR DISEASE IN WORKERS EMPLOYED IN HAZARDOUS WORKING CONDITIONS AT RADIATION HAZARDOUS ENTERPRISE | 2023 |
|
RU2816338C1 |
| DIAGNOSTIC TECHNIQUE FOR PULMONARY THROMBOEMBOLISM BASED ON MEASURING BLOOD SERUM INTERLEUKIN-8 | 2013 |
|
RU2549988C1 |
